News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
279,583 Results
Type
Article (9829)
Company Profile (49)
Press Release (269705)
Section
Business (80220)
Career Advice (397)
Deals (17543)
Drug Delivery (27)
Drug Development (43164)
Employer Resources (57)
FDA (7006)
Job Trends (6237)
News (147776)
Policy (12483)
Tag
Academia (782)
Alliances (18140)
Alzheimer's disease (705)
Approvals (7033)
Bankruptcy (148)
Best Places to Work (5514)
Biotechnology (50)
Breast cancer (111)
Cancer (744)
Career advice (348)
Cell therapy (123)
Clinical research (35436)
Collaboration (217)
Compensation (95)
COVID-19 (962)
C-suite (51)
Data (898)
Diabetes (81)
Diagnostics (2728)
Earnings (39630)
Employer resources (50)
Events (37000)
Executive appointments (191)
FDA (7406)
Funding (164)
Gene therapy (64)
GLP-1 (221)
Government (1039)
Healthcare (7009)
Infectious disease (1001)
Inflammatory bowel disease (60)
Interviews (60)
IPO (9464)
Job creations (1004)
Job search strategy (311)
Layoffs (73)
Legal (2195)
Lung cancer (116)
Lymphoma (52)
Manufacturing (79)
Medical device (4964)
Medtech (4965)
Mergers & acquisitions (8274)
Metabolic disorders (193)
Neuroscience (846)
NextGen Class of 2024 (1963)
Non-profit (830)
Northern California (979)
Obesity (81)
Opinion (49)
Parkinson's disease (44)
Patents (71)
People (19865)
Phase I (10724)
Phase II (15659)
Phase III (12179)
Pipeline (374)
Postmarket research (1046)
Preclinical (4301)
Radiopharmaceuticals (88)
Rare diseases (116)
Real estate (1526)
Regulatory (9893)
Research institute (722)
Resumes & cover letters (46)
Southern California (850)
Startups (942)
United States (8060)
Vaccines (150)
Weight loss (45)
Date
Last 7 days (325)
Last 30 days (1267)
Last 365 days (19469)
2024 (19354)
2023 (22149)
2022 (30080)
2021 (31184)
2020 (27137)
2019 (16884)
2018 (12603)
2017 (13715)
2016 (11508)
2015 (14479)
2014 (10159)
2013 (7317)
2012 (8092)
2011 (8716)
2010 (8287)
Location
Africa (213)
Asia (16797)
Australia (2027)
California (2124)
Canada (977)
China (159)
Colorado (84)
Connecticut (84)
Europe (31250)
Florida (337)
Georgia (67)
Illinois (123)
Indiana (108)
Japan (57)
Kansas (55)
Maryland (307)
Massachusetts (1499)
Michigan (65)
Minnesota (105)
New Jersey (680)
New York (666)
North Carolina (346)
Northern California (979)
Ohio (59)
Pennsylvania (540)
South America (387)
Southern California (850)
Texas (329)
Utah (63)
Washington State (271)
279,583 Results for "factor bioscience".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Factor Bioscience Successfully Defends Three U.S. Patents Covering Foundational Methods for Therapeutic Gene Editing
Factor Bioscience Inc. today announced that the United States Patent and Trademark Office (USPTO) has terminated three separate ex parte reexaminations of three U.S. patents owned by Factor.
May 28, 2024
·
3 min read
Business
Factor Bioscience Expands Translational Science Team, Appoints Kyle Garland, Ph.D., as Director of Translational Science
Factor Bioscience Inc. today announced the addition of three members to its translational science team, which will be led by Kyle Garland, Ph.D., who joins Factor as Director of Translational Science.
April 9, 2024
·
1 min read
Genetown
Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting
Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy (ASGCT) 27th Annual Meeting to be held in Baltimore, MD from May 7-11, 2024.
April 23, 2024
·
3 min read
Press Releases
Factor Bioscience and Eterna Therapeutics Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases
October 18, 2024
·
4 min read
Press Releases
Eterna Therapeutics and Factor Bioscience Announce Exclusive License and Collaboration Agreement to Accelerate Cell Therapy Development for Oncology, Autoimmune, and Rare Diseases
October 17, 2024
·
4 min read
Business
Factor Bioscience Announces U.S. Department of Defense Grant to Develop Gene-Edited Cell Therapies
Factor Bioscience Inc. announced the award of a U.S. Department of Defense grant to develop next-generation cell therapy candidates using Factor’s patented mRNA, cell-reprogramming, and gene-editing technologies.
January 9, 2024
·
2 min read
News
Factor Bioscience to Deliver Presentations at the International Society for Stem Cell Research 2024 Meeting
July 9, 2024
·
3 min read
FDA
FDA-approved TIVDAK®: Targeting Tissue Factor in Cervical Cancer
On April 29th, 2024, the U.S. FDA granted full approval for Seagen Inc.'s TIVDAK® (tisotumab vedotin) targeting tissue factor (TF) for the treatment...
May 10, 2024
·
1 min read
BioMidwest
New CIMZIA® data for women living with chronic rheumatic diseases throughout pregnancy, and for people living with RA and high rheumatoid factor levels
UCB, a global biopharmaceutical company, will present results from three studies for CIMZIA®, a PEGylated fragment crystalized -free tumor necrosis factor inhibitor, for women of childbearing age living with chronic immune-mediated diseases and people with rheumatoid arthritis and high rheumatoid factor levels.
June 13, 2024
·
24 min read
Press Releases
Panavance Announces New Discovery that Misetionamide Directly Inhibits Oncogenic Transcription Factor c-MYC
November 19, 2024
·
3 min read
1 of 27,959
Next
